North America

Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…

There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in…

In 2023, still relatively high inflation continues to impact prices of essentials, such as groceries, as well as consumer health products, including OTC remedies, vitamins and dietary supplements and sports nutrition. However, consumer demand remains…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

Cough and cold remedies/products are expected to enjoy demand in 2023. However, the shortages of cough and cold medicines, which provided a consistent disruption in 2022, lingered in 2023. Against this background, manufacturers have struggled to keep…

In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…

Dermatologicals is projected to continue to see positive, if slow, retail value (constant 2023 prices) growth in 2023. However, after posting robust retail volume gains in 2021 and 2022, most categories are projected to see declines in retail volume…

2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…

Having witnessed spikes in retail volume sales due to heightened awareness of the importance of health with the onset of the Coronavirus (COVID-19) pandemic, dietary supplements continues to stabilise in 2023. Probiotics supplements are set to…

Following the initial high growth phase of the pandemic in 2020, and subsequent slowdown in growth in 2021 as panic-buying receded, dietary supplements has re-entered a period of consistency, and is set to continue to grow at a moderate pace in…

Canadian consumers have resumed pre-pandemic lifestyles, with COVID-19 restrictions lifted fully in mid-2022. The return to hectic, out-of-home lifestyles fosters unhealthy diets and irregular eating habits and increases sales for digestive remedies,…

Natural digestive remedies and DTC supplement brands have witnessed an incredible online revolution in recent years, due to increased TikTok education on homeopathic treatments and awareness of holistic gut supplements. There has been growing…

Eye care is projected to post positive retail value (constant 2023 prices) growth in 2023. While moderate, growth is expected to be higher than in the previous years of the review period, partly due to strong unit price increases. Meanwhile, in…

In 2023, standard eye care is set to outperform allergy eye care, due to the year-round use of such products, as well as consumers’ growing concern about issues such as dry eye and digital eye strain. Although price increases from eye care players…

Most herbal/traditional categories are expected to see decreases in retail volume sales over 2023, although this comes on the back of strong growth in the wake of the Coronavirus (COVID-19) crisis earlier in the review period. In 2023, the market…

Across digestive health, sleep aids, dietary supplements, weight management, and sleep aids, natural options formulated from botanical blends have skyrocketed in popularity post-COVID-19, as consumers have become increasingly educated on highlighted…

NRT smoking cessation aids is projected to see positive retail value (constant 2023 prices) growth over 2023. While retail volume sales are set to decline, partly due to maturity in 2023, following the registering of significant growth earlier in the…

NRT patches is set to continue to witness steep volume and current value declines in 2023, as the topical option struggles to gain momentum against the rising popularity of newer, more convenient oral alternatives. In recent years, the rise of…

Paediatric cough/cold remedies is projected to deliver further strong retail volume and value (constant 2023 prices) growth in 2023. The growth in demand for these products is informed by the supply shortages of paediatric cold and flu remedies in…

It is evident that the average consumer has become more health-conscious since COVID-19, as seen through transformations in ingredient-focused product development in dermatologicals, alongside the rise of natural remedies and botanical compositions…